NASDAQ:ETNB
Delisted

89bio Stock Forecast

etoro logo Buy ETNB
*Your capital is at risk
$14.84
+0 (+0%)
At Close: Jan 29, 2026

ETNB Performance

FAQ

What is the symbol for 89bio, Inc. Stock and on which exchange is it traded?
The symbol for 89bio, Inc. is ETNB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell 89bio, Inc. Stock?
89bio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy 89bio, Inc. Stock?
89bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy 89bio, Inc. Stock.

What's the current price of 89bio, Inc. Stock?
As of the end of day on the Jan 29, 2026, the price of an 89bio, Inc. (ETNB) share was $14.84.

What is the 52-week high and low for 89bio, Inc. Stock?
The 52-week high for 89bio, Inc. Stock is $15.06 and the 52-week low is $4.16.

What is the market capitalization of 89bio, Inc. Stock?
As of the Jan 29, 2026, the market capitalization of 89bio, Inc. is 2.201B.
Click to get the best stock tips daily for free!
ABOUT 89BIO, INC.
89bio
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorpor...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE